Literature DB >> 16175213

Retigabine: bending potassium channels to our will.

Andre Lagrange.   

Abstract

Year:  2005        PMID： 16175213      PMCID： PMC1201633          DOI： 10.1111/j.1535-7511.2005.00052.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  8 in total

Review 1.  Potassium channels: structures, models, simulations.

Authors:  Mark S P Sansom; Indira H Shrivastava; Joanne N Bright; John Tate; Charlotte E Capener; Philip C Biggin
Journal:  Biochim Biophys Acta       Date:  2002-10-11

Review 2.  Stirring up controversy with a voltage sensor paddle.

Authors:  Christopher A Ahern; Richard Horn
Journal:  Trends Neurosci       Date:  2004-06       Impact factor: 13.837

3.  Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII).

Authors:  Meir Bialer; Svein I Johannessen; Harvey J Kupferberg; René H Levy; Emilio Perucca; Torbjörn Tomson
Journal:  Epilepsy Res       Date:  2004 Sep-Oct       Impact factor: 3.045

4.  The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate.

Authors:  Thomas V Wuttke; Guiscard Seebohm; Sigrid Bail; Snezana Maljevic; Holger Lerche
Journal:  Mol Pharmacol       Date:  2005-01-20       Impact factor: 4.436

5.  Effect of the KCNQ potassium channel opener retigabine on single KCNQ2/3 channels expressed in CHO cells.

Authors:  L Tatulian; D A Brown
Journal:  J Physiol       Date:  2003-04-17       Impact factor: 5.182

Review 6.  Pharmacology of cardiac potassium channels.

Authors:  Juan Tamargo; Ricardo Caballero; Ricardo Gómez; Carmen Valenzuela; Eva Delpón
Journal:  Cardiovasc Res       Date:  2004-04-01       Impact factor: 10.787

7.  Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine.

Authors:  Anne Schenzer; Thomas Friedrich; Michael Pusch; Paul Saftig; Thomas J Jentsch; Joachim Grötzinger; Michael Schwake
Journal:  J Neurosci       Date:  2005-05-18       Impact factor: 6.167

8.  Acetylcholine receptor channel structure in the resting, open, and desensitized states probed with the substituted-cysteine-accessibility method.

Authors:  G Wilson; A Karlin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205
  8 in total
  2 in total

1.  Ezogabine: a new angle on potassium gates.

Authors:  Edward Faught
Journal:  Epilepsy Curr       Date:  2011-05       Impact factor: 7.500

2.  Ion Channel Drugs Suppress Cancer Phenotype in NG108-15 and U87 Cells: Toward Novel Electroceuticals for Glioblastoma.

Authors:  Juanita Mathews; Franz Kuchling; David Baez-Nieto; Miranda Diberardinis; Jen Q Pan; Michael Levin
Journal:  Cancers (Basel)       Date:  2022-03-15       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.